Sonendo, a Laguna Hills, Calif.-based tooth decay medical technology company, plans to raise up to $133 million in an offering of 7.8 million shares priced between $15 and $17 per share, per Fortune’s Term Sheet. The company reported $23 million in revenue in 2020 and a net loss of $47 million. General Atlantic, OrbiMed, Meritech Capital, and EW Healthcare Partners back the firm.
Sonendo Plans $133M IPO
